Remdesivir that is an anti-Ebola drug that was provided for the E-bola treatment. Gilead has been working on this drug since 2009 when the Ebola hit the human beings and it’s treatment cause was much more needed. The data required this drug will be expected in weeks and then any official decisions can be made for the use of this treatment for the Covid-19. Not only this president Trump also stated about this particular drug that it has a good probability to treat the coronavirus. it has been tested on both mild and severe case of coronavirus for now.
The other drug that is a potential contender to treat the Coronavirus is called as Kaletra, it is an HIV drug that is also being in tested with various human trials. Manufactured by AbbVie, on the other hand, the early research that has been conducted about the drug did not show positive results. Since it has been indicated that the mortality rate of humans has not been improved by the drug according to the research conducted last month.
Chloroquine is an anti-malaria drug is also a potential contender in this line and it was created in 1949. So, this drug is highly common among the human beings. Donald Trump also highlighted this particular drug in his statement, this drug was approved in World War-II by the FDA. Therefore, if this drug can treat Coronavirus, then its safety problem does not need to checked or tested for a longer period of time. Early research has indicated positive results, that this drug can fight Covid-19 and therefore it is also a cheap option for the solution. additionally, guidelines designed to treat coronavirus by countries like China, Belgium, have also stated the use of Chloroquine for the treatment of the Covid-19.
As Preventive coronavirus treatments, monoclonal antibodies that is mostly indicated as a type of the protein that will be able to help the human bodies to fight the virus has also been indicated as a potential contender for fighting Covid-19. In January, Vir Biotechnology is a company that stated, that they are working on the same treatment for fighting the Covid-19. This drug will be used in a manner, that it would be given to the high-risk patient population, like healthcare personnel who are working day and night for treating the patients, family members of the Covid-19. Therefore, these bodies are the target for Covid-19, and they should be given the medicine in order to create the antibodies to protect the others. But for now, this treatment is on its very early stages of research and a lot is to be figured about this particular treatment.
